According to our findings, since CD81 promotes Rad51-dependent DNA repair and thus acts as an intrinsic factor of tumor radioresistance, we speculate that combination of radiotherapy and CD81 inhibitor may promote therapeutic effect by attenuating HRR in GBM. The gene discussed is CD81; the disease is neoplasm.